NextGen Omics, Spatial & Data US 2026

Sheraton Boston Hotel, Boston, MA
.webp?width=1553&height=425&name=NextGen%20Omics%2c%20Spatial%20%26%20Data%20US%202026%20Logo%20(1).webp)
Where Big Attendance Meets Intimate Connections
Highlights of the Two-Day Event
March 31 – April 01, 2026 | Sheraton Boston Hotel, Boston, MA, USA
Don’t miss our Cross Program Panel Discussions taking place across both days of the event. Join leading experts & industry innovators as they tackle critical themes shaping the future of omics research. These dynamic, interactive sessions will explore the latest breakthroughs and challenges in the use of artificial intelligence, navigating the research funding landscape, and celebrating the role of women in genomics.
Revolutionizing Multi-Omics Research With Artificial Intelligence
Discover how both industry and academia are approaching the AI revolution as they debate the potential role of generative AI in medical research, what the potential limitations of AI are, and where AI could take us in the near future.
Omics Research Under Fiscal Constraint
Hear strategies for prioritizing, sustaining, or reconfiguring research in resource limited settings. Gain insights into new initiatives to fund young researchers and cultivate new start-up opportunities
Celebrating Women in Genomics
Join a group of thought leaders from across the omics field to discuss the journey of breaking traditional barriers in STEM, individual case studies form pharma and academic research career journeys, and reflections on women’s newest and greatest contributions to genomic science
Engage with our Young Scientist Award nominees at their posters in our exhibition hall to hear about the multi-omics work being conducted by PhD students, Postdocs, and early career scientists. Join us at 18:40 to hear who our three winners are and explore their work in more depth as the top five present on day two.
Stephen Bruce Baylin, Deputy Director & Associate Director for Research, Sidney Kimmel Comprehensive Cancer
A world-renowned leader in cancer research and a pioneer in the field of epigenetics. Dr. Baylin has made groundbreaking contributions to our understanding of how epigenetic changes—can drive cancer development and progression. His research has been instrumental in revealing how the silencing of tumor suppressor genes through DNA methylation and other epigenomic mechanisms contributes to tumor behavior. Join him on Day 2 as he delves into his latest research.
Mark your calendars for our cross-program roundtables on day two of the event. Join in from 14:05 – 14:55 and choose from eight key topic areas, each with one of our experts, in a lively informal setting to revitalize after lunch
Connect and Network
Experience an event that celebrates meaningful, one-on-one connections in a dynamic, bustling atmosphere. With NextGen Omics, Spatial & Data, enjoy a vibrant crowd with the warmth of personal interactions and curated experiences